Barlow (n = 27) | FED (n = 32) | Control (n = 18) | |
---|---|---|---|
Age (years) | 51 ± 14a | 62 ± 12 | 57 ± 16 |
Woman (n, %) | 10 (37 %) | 13 (41 %) | 7 (39 %) |
BSA (m2) | 1.90 ± 0.19 | 1.95 ± 0.23 | 1.87 ± 0.24 |
Hypertension | 13 (48 %)a | 26 (82 %)b | 10 (57 %) |
Diabetes | 3 (11 %)b | 3 (9 %)b | 0 |
EF (%) | 66.2 ± 5.8 | 67.1 ± 6.1 | 65.4 ± 5.3 |
LV EDV (ml) | 133.1 ± 49.9 | 128.2 ± 40.8 | 105.5 ± 29.4 |
LV ESV (ml) | 44 ± 18.4 | 43.9 ± 12.7 | 37.5 ± 16.5 |
LAVi (ml/m2) | 52.7 ± 13.7b | 57.7 ± 29.5b | 36.9 ± 8.6 |
PAPs (mm Hg) | 38 ± 8a,b | 47 ± 16b | 29 ± 5 |
MR (n, %) | |||
None | 0b | 0b | 6 (33 %) |
Mild | 0b | 0b | 11 (61 %) |
Moderate | 11 (41 %)a,b | 2 (6 %) | 1 (6 %) |
Severe | 16 (59 %)a,b | 30 (94 %)b | 0 |
Flail | 10 (37)a,b | 26 (81 %)b | 0 |
Cleft | 6 (22 %)a,b | 12 (38 %)b | 0 |